The use of p16INK4a immunocytochemistry in "Atypical squamous cells which cannot exclude HSIL" compared with "Atypical squamous cells of undetermined significance" in liquid-based cervical smears

Diagnostic Cytopathology

Volumn 38, Issue 3, 2010, Pages 168-171

  Chang, Ohk Sung ^a   Seong, Rim Kim ^b   Young, Lyun Oh ^a   Sang, Yong Song ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Medplan Pathology Laboratory Center   (South Korea)

Author keywords

ASC H; ASC US; Human papillomavirus; Immunocytochemistry; p16

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P16;

ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; BIOPSY; CANCER CELL; CANCER SCREENING; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS LOAD; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIRAL LOAD;

EID: 76149123894     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21164     Document Type: Article

References (17)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
2. Lieu D. The Papanicolaou smear: Its value and limitations. J Fam Pract 1996;42:391-399.
3. Uyar DS, Eltabbakh GH, Mount SL. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant. Gynecol Oncol 2003;89:227-232.
4. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390.
5. Legood R, Gray A, Wolstenholme J, Moss S. Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: Results of the NHS pilot studies. BMJ 2006;332:79-85.
6. Melnikow J, Birch S. Human papillomavirus triage of atypical squamous cells of undetermined significance: Cost-effective, but at what cost? J Natl Cancer Inst 2006;98:82-83.
7. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299.
8. Benevolo M, Mottolese M, Marandino F, et al. Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol 2006;19:384-391.
9. Longatto Filho A, Utagawa ML, Shirata NK, et al. Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus. Int J Gynecol Pathol 2005;24:118-124.
10. Bose S, Evans H, Lantzy L, Scharre K, Youssef E. p16(INK4a) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear. Diagn Cytopathol 2005;32:21-24.
11. Monsonego J, Pollini G, Evrard MJ, et al. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: Added value in management of women with equivocal Pap smear. Acta Cytol 2007;51:755-766.
12. Nieh S, Chen SF, Chu TY, et al. Is p16(INK4a) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol Oncol 2005; 97:35-40.
13. Shin EK, Lee SR, Kim MK, et al. Immunocytochemical staining of p16(ink4a) protein as an adjunct test in equivocal liquid-based cytology. Diagn Cytopathol 2008;36:311-316.
14. Sahebali S, Depuydt CE, Segers K, et al. p16INK4a as an adjunct marker in liquid-based cervical cytology. Int J Cancer 2004;108: 871-876.
15. Samama B, Schaeffer C, Boehm N. P16 expression in relation to human papillomavirus in liquid-based cervical smears. Gynecol Oncol 2008;109:285-290.
16. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001;7:584-589.
17. Kang S, Kim J, Kim HB, et al. Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia. Diagn Mol Pathol 2006;15:74-82.